Back to MORGAN STANLEY MORGAN STANLEY

SKYESKYE
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in SKYE BIOSCIENCE INC

Yes. Morgan Stanley holds 2,469 shares of SKYE (Skye Bioscience), worth $1,711, as of its Q2 2026 13F filing. It reduced the position by 80 shares (-3.1%) from Q1 2026. Morgan Stanley has held SKYE in every 13F on record since Q2 2024, 9 quarterly filings.

Current Value

$1,711

Current Shares

2,469

Total Value Change

-$222,691

Total Shares Change

-54,923

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2,469
-3.1%
$1,7110.0%$5.54
0
2026-Q1
Decreased
2,549
-40.3%
$1,5670.0%$4.92
0
2025-Q4
Decreased
4,269
-13.8%
$3,2000.0%$6.00
0
2025-Q3
Decreased
4,952
-44.0%
$19,4610.0%$31.44
0
2025-Q2
Decreased
8,840
-72.3%
$36,9510.0%$33.44
0
2025-Q1
Decreased
31,880
-47.8%
$50,6890.0%$12.72
0
2024-Q4
Increased
61,026
+6.3%
$172,7040.0%$22.64
16
2024-Q3
Increased
57,392
+167.3%
$224,4020.0%$31.28
25

Other major holders of SKYE: BlackRock Finance, Inc., Janus Henderson Group Ltd., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used